Apimeds completes 1-for-10 reverse stock split; share count falls to 1.51M

Apimeds Pharmaceuticals US, Inc.

Reverse stock split effective 12:01 a.m. ET on July 24, 2026; every 10 shares combined into 1 share.
Shares outstanding reduced from 15,091,180 to 1,509,118; 33,506 additional shares issued for fractional rounding.
Par value reduced from $0.01 to $0.001 per share; authorized shares unchanged at 100M common, 10M preferred.
Common stock trades on NYSE American under 'APUS' on split-adjusted basis; new CUSIP 03771D201.
Proportionate adjustments made to outstanding equity awards and warrants and their exercise prices.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.